Clinical Trials on Human Immunodeficiency Virus Type 1 in Finland
Total 381 results
-
Janssen R&D IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, Belgium, Spain, Switzerland, Sweden, Canada, Puerto Rico, Poland
-
GlaxoSmithKlineCompletedHIV Infection | HIV-1 Infection | Infection, Human Immunodeficiency Virus INetherlands, Finland, Ireland, Portugal, Switzerland
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruiting
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Canada
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsCompletedHIV Infections | Infection, Human Immunodeficiency VirusGermany, Spain, France, United States, Canada
-
Rhode Island HospitalVirtually Better, Inc.CompletedMental Health | Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusSpain, France, Germany, United States, Italy, Romania, Russian Federation, Switzerland, Puerto Rico
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, Canada, Portugal, Italy, Belgium
-
ViiV HealthcareGlaxoSmithKline; PPDCompletedHIV Infections | Infection, Human Immunodeficiency VirusTaiwan, France, Germany, Belgium, United States, Canada, Netherlands, Spain, Korea, Republic of, Italy, Australia, United Kingdom, Russian Federation, Portugal, Argentina, South Africa, Romania, Mexico
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency Virus IUnited States, Spain, Germany, Australia, Canada, Belgium, Denmark, Netherlands, United Kingdom, France, Italy, Romania
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency VirusUnited States, Belgium, France, Germany, Spain, Canada, Italy, Portugal, Romania, Austria, Switzerland, Poland, Latvia, Luxembourg
-
ViiV HealthcareTerminatedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, France, Canada, Germany, Italy, Belgium, United Kingdom, Portugal, Spain
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, Canada, Puerto Rico
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, France, Netherlands, Spain, Taiwan, Australia, Belgium, Russian Federation, Canada, United Kingdom, Mexico, Italy, South Africa, Romania, Argentina, Hungary, Poland, Chile, Greece, Brazil
-
Gilead SciencesCompletedHepatitis C | Human Immunodeficiency VirusUnited States, Puerto Rico
-
Riitta VeijolaTurku University Hospital; Juvenile Diabetes Research Foundation; University... and other collaboratorsRecruiting
-
Marjukka KolehmainenKuopio University Hospital; Raisio PlcCompleted
-
Helsinki University Central HospitalMedtronic International Trading SarlRecruiting
-
Central Finland Hospital DistrictUniversity of Jyvaskyla; Finnish Diabetes AssociationCompleted
-
Rhode Island HospitalRecruitingOpioid Use Disorder | Human Immunodeficiency VirusUnited States
-
University of TurkuOulu University Hospital; University of Helsinki; Tampere UniversityUnknown
-
GlaxoSmithKlineCompleted
-
Novartis VaccinesCompleted
-
MedImmune LLCWyeth is now a wholly owned subsidiary of PfizerCompleted
-
Finnish Institute for Health and WelfareHospital District of Helsinki and UusimaaRecruiting
-
Finnish Institute for Health and WelfareRWTH Aachen University; University of ErfurtCompleted
-
Turku University HospitalAcademy of FinlandCompleted
-
NovartisNovartis VaccinesCompleted
-
Finnish Institute for Health and WelfareCompletedInfluenza Caused by the 2009 H1N1 Influenza VirusFinland
-
Finnish Institute for Health and WelfareCompletedInfluenza Caused by the Novel A(H1N1)v Influenza VirusFinland
-
University of OuluTurku University Hospital; Oulu University Hospital; Tampere University HospitalEnrolling by invitation
-
Sanofi Pasteur, a Sanofi CompanyTerminated
-
Gilead SciencesCompletedHIV Infections | Acquired Immunodeficiency Syndrome | HIV-1United States, Canada
-
Brown UniversityThe Miriam Hospital; National Institute of General Medical Sciences (NIGMS)RecruitingAlcohol Drinking | HIV-1-infectionUnited States
-
Hospital District of Southwestern FinlandHoffmann-La RocheCompleted
-
Novartis VaccinesCompletedProphylaxis of Avian InfluenzaFinland
-
NovartisNovartis VaccinesCompletedPandemic Influenza DiseaseFinland, Germany
-
University of OuluTurku University Hospital; Oulu University Hospital; Tampere University Hospital and other collaboratorsCompleted
-
University of OuluTurku University Hospital; Oulu University Hospital; Tampere University Hospital and other collaboratorsCompleted
-
SanofiCompletedInfluenza Immunization (Healthy Volunteers)Finland, Germany
-
Janssen Research & Development, LLCCompletedPre-Symptomatic Type 1 DiabetesUnited States, Finland, Sweden
-
University of HelsinkiNovo Nordisk A/S; Juvenile Diabetes Research Foundation; European Union; Academy... and other collaboratorsCompleted
-
Ology BioservicesCompletedInfluenza | Avian InfluenzaAustria, Finland
-
Medtronic DiabetesActive, not recruitingDiabetes type1 | Children, OnlyItaly, United Kingdom, Finland, Slovenia
-
Helsinki University Central HospitalUnknownMeasurement of Immune Response to Prevenar13 | Measurement of Immune Response to Hepatitis AFinland, Sweden
-
National Institute of Diabetes and Digestive and...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsActive, not recruitingType 1 Diabetes MellitusUnited States, Finland, Germany, Sweden
-
University of HelsinkiActive, not recruitingType1diabetes | Celiac DiseaseFinland